LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 30.64 | 17.25 | 958 | 1887 | 0.5076 | 0.8095 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.61 | 17.25 | 1 | 2136 | 0.0005 | -0.3361 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.61 | 17.25 | 878 | 2136 | 0.4110 | 0.7599 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.61 | 17.25 | 116 | 2136 | 0.0543 | 0.3154 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 32.61 | 17.25 | 934 | 2136 | 0.4372 | 0.7756 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.57 | 17.25 | 1 | 2523 | 0.0004 | -0.3270 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.57 | 17.25 | 862 | 2523 | 0.3416 | 0.7226 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.57 | 17.25 | 216 | 2523 | 0.0856 | 0.4211 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 34.57 | 17.25 | 965 | 2523 | 0.3825 | 0.7498 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.54 | 17.25 | 1 | 2679 | 0.0004 | -0.3238 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.54 | 17.25 | 867 | 2679 | 0.3235 | 0.7128 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.54 | 17.25 | 157 | 2679 | 0.0586 | 0.3544 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 36.54 | 17.25 | 935 | 2679 | 0.3489 | 0.7307 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.51 | 17.25 | 1 | 2906 | 0.0003 | -0.3196 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.51 | 17.25 | 868 | 2906 | 0.2987 | 0.6985 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.51 | 17.25 | 96 | 2906 | 0.0330 | 0.2612 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 38.51 | 17.25 | 906 | 2906 | 0.3118 | 0.7084 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.48 | 17.25 | 1 | 3125 | 0.0003 | -0.3159 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.48 | 17.25 | 824 | 3125 | 0.2636 | 0.6743 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.48 | 17.25 | 49 | 3125 | 0.0157 | 0.1493 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 40.48 | 17.25 | 916 | 3125 | 0.2931 | 0.6981 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.45 | 17.25 | 1 | 3504 | 0.0003 | -0.3103 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.45 | 17.25 | 803 | 3504 | 0.2292 | 0.6503 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.45 | 17.25 | 46 | 3504 | 0.0131 | 0.1365 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.45 | 17.25 | 904 | 3504 | 0.2580 | 0.6760 | MN20160310_N02 | K04 |